AbbVie (ABBV) Capital Expenditures (2012 - 2026)
AbbVie (ABBV) reported Capital Expenditures of $322 million for Q2 2026, up 19.7% from $269 million a year earlier and up 21.5% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Capital Expenditures (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, AbbVie's Capital Expenditures came in at $1.3 billion, up 24.2% year-over-year; for FY2025, it came in at $1.21 billion, up 24.6% from FY2024.
- Capital Expenditures has increased for three consecutive years, with a five-year compound annual growth rate of 8.8% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $974 million in FY2024 (+25.4%), $777 million in FY2023 (+11.8%), $695 million in FY2022 (-11.7%) and $787 million in FY2021 (-1.4%).
- Five-year quarterly Capital Expenditures spans a low of $143 million in Q2 2022 and a high of $381 million in Q3 2025.
- Year over year, Capital Expenditures has now increased in each of the last ten quarters, with growth averaging 23.4% over the last eight quarters.
- The high point for year-over-year Capital Expenditures in five years was Q3 2025 (growth of 53.0%); the low point was Q4 2021 (a decline of 33.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $265 million (Q1 2026), $329 million (Q4 2025) and $381 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 305.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 322.00 Mn |
| Mar 31, 2026 | 265.00 Mn |
| Dec 31, 2025 | 329.00 Mn |
| Sep 30, 2025 | 381.00 Mn |
| Jun 30, 2025 | 269.00 Mn |
| Mar 31, 2025 | 235.00 Mn |
| Dec 31, 2024 | 291.00 Mn |
| Sep 30, 2024 | 249.00 Mn |
| Jun 30, 2024 | 241.00 Mn |
| Mar 31, 2024 | 193.00 Mn |
| Dec 31, 2023 | 205.00 Mn |
| Sep 30, 2023 | 219.00 Mn |
| Jun 30, 2023 | 178.00 Mn |
| Mar 31, 2023 | 175.00 Mn |
| Dec 31, 2022 | 213.00 Mn |
| Sep 30, 2022 | 177.00 Mn |
| Jun 30, 2022 | 143.00 Mn |
| Mar 31, 2022 | 162.00 Mn |
| Dec 31, 2021 | 187.00 Mn |
| Sep 30, 2021 | 217.00 Mn |
API Access
AbbVie Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();